Pacira BioSciences
PCRX
187 hedge funds and large institutions have $3.03B invested in Pacira BioSciences in 2015 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 73 increasing their positions, 63 reducing their positions, and 47 closing their positions.
30% more call options, than puts
Call options by funds: $31.6M | Put options by funds: $24.3M
16% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 63
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
9% less funds holding
Funds holding: 205 → 187 (-18)
15% less capital invested
Capital invested by funds: $3.58B → $3.03B (-$553M)
34% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 47
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$124M |
| 2 |
HCM
Hoplite Capital Management
New York
|
+$99.4M |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
+$60.3M |
| 4 |
Goldman Sachs
New York
|
+$58.9M |
| 5 |
VAM
Visium Asset Management
New York
|
+$48.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$92.5M |
| 2 |
RIM
RS Investment Management
San Francisco,
California
|
-$54.3M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$35.5M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$29.5M |
| 5 |
HCM
Hodges Capital Management
Dallas,
Texas
|
-$26.2M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CIM
226
CIM Investment Management
Pittsburgh,
Pennsylvania
| – | -$210K | -2,363 | Closed |
|
|
MAM
227
Martingale Asset Management
Boston,
Massachusetts
| – | -$205K | -2,300 | Closed |
|
228
Creative Planning
Overland Park,
Kansas
| – | -$98K | -1,100 | Closed |
|
|
SEC
229
Seven Eight Capital
New York
| – | -$53K | -601 | Closed |
|
|
SF
230
Synovus Financial
Columbus,
Georgia
| – | -$16K | -180 | Closed |
|
|
PSI
231
Pinnacle Summer Investments
Fairfax,
Virginia
| – | -$10K | -110 | Closed |
|
|
WAS
232
Winch Advisory Services
Appleton,
Wisconsin
| – | -$9K | -100 | Closed |
|
|
WTB
233
Washington Trust Bank
Spokane,
Washington
| – | -$4K | -50 | Closed |
|
|
KCPG
234
Kavar Capital Partners Group
Leawood,
Kansas
| – | +$788 | +10 | New |
|
PCRX Hedge Fund Activity: Q2 2015 in Review
187 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Pacira BioSciences (PCRX) for Q2 2015, worth a combined $3.03B — down 15% from $3.58B a quarter earlier.
Sellers outnumbered buyers: 47 funds closed out of PCRX and 31 opened new positions — a net loss of 16 holders — while 63 trimmed existing stakes and 73 added.
The largest buyer was Janus Henderson Investors US, adding an estimated $124M. The largest seller was Jennison Associates, cutting an estimated $92.5M.
- 187 institutional investors held Pacira BioSciences (PCRX) as of Q2 2015, down from 205 in Q1 2015.
- Funds reported $3.03B of Pacira BioSciences stock for Q2 2015, down 15% quarter-over-quarter.
- 31 funds opened new Pacira BioSciences positions in Q2 2015 and 47 closed out, a net change of -16 holders.
- The largest Pacira BioSciences buyer in Q2 2015 was Janus Henderson Investors US, an estimated $124M added.
- The largest Pacira BioSciences seller in Q2 2015 was Jennison Associates, an estimated $92.5M sold.
Based on aggregated 13F filings for Q2 2015.